4.6 Article

Regulation of Myc by miR-34c A mechanism to prevent genomic instability?

期刊

CELL CYCLE
卷 9, 期 14, 页码 2726-2730

出版社

TAYLOR & FRANCIS INC
DOI: 10.4161/cc.9.14.12182

关键词

microRNA; cell cycle; DNA damage; P38

向作者/读者索取更多资源

Over the past 8 years several lines of compelling evidence have indicated that microRNAs are critical downstream effectors of classic oncogene/tumour suppressor networks. The archetypal examples of oncogene and tumour suppressor microRNAs are the miR-17-92 (oncomir 1) polycistron and miR-34 respectively. Whilst the involvement of these two opposing families of microRNAs in oncogenesis has been known for some time, the mRNA targets through which they exert their phenotypes are only just beginning to be uncovered. Moreover, several recent reports have demonstrated that the relevant physiological targets of certain individual microRNAs are actually fairly limited, with repression of just one or two major targets sufficient to explain the observed phenotype. In this review we will discuss the emerging role of microRNAs in tumourigenesis with a specific focus on miR-34c-dependent regulation of Myc.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Oncology

A Pleiotropic RNA-Binding Protein Controls Distinct Cell Cycle Checkpoints to Drive Resistance of p53-Defective Tumors to Chemotherapy

Ian G. Canne, Karl A. Merrick, Sandra Morandell, Chang-Qi Zhu, Christian J. Braun, Robert A. Grant, Eleanor R. Cameron, Ming-Sound Tsao, Michael T. Hemann, Michael B. Yaffe

CANCER CELL (2015)

Correction Oncology

A Pleiotropic RNA-Binding Protein Controls Distinct Cell Cycle Checkpoints to Drive Resistance of p53-Defective Tumors to Chemotherapy (vol 28, pg 623, 2015)

Ian G. Cannell, Karl A. Merrick, Sandra Morandell, Chang-Qi Zhu, Christian J. Braun, Robert A. Grant, Eleanor R. Cameron, Ming-Sound Tsao, Michael T. Hemann, Michael B. Yaffe

CANCER CELL (2015)

Article Cell Biology

A common polymorphism in the 5′ UTR of ERCC5 creates an upstream ORF that confers resistance to platinum-based chemotherapy

Joanna Somers, Lindsay A. Wilson, John-Paul Kilday, Emilie Horvilleur, Ian G. Cannell, Tuija A. A. Poeyry, Laura C. Cobbold, Alexander Kondrashov, John R. P. Knight, Stephanie Puget, Jacques Grill, Richard G. Grundy, Martin Bushell, Anne E. Willis

GENES & DEVELOPMENT (2015)

Article Cell Biology

Is post-transcriptional stabilization, splicing and translation of selective mRNAs a key to the DNA damage response?

H. Christian Reinhardt, Ian G. Cannell, Sandra Morandell, Michael B. Yaffe

CELL CYCLE (2011)

Article Biochemistry & Molecular Biology

Programming of adipose tissue miR-483-3p and GDF-3 expression by maternal diet in type 2 diabetes

D. Ferland-McCollough, D. S. Fernandez-Twinn, I. G. Cannell, H. David, M. Warner, A. A. Vaag, J. Bork-Jensen, C. Brons, T. W. Gant, A. E. Willis, K. Siddle, M. Bushell, S. E. Ozanne

CELL DEATH AND DIFFERENTIATION (2012)

Editorial Material Critical Care Medicine

Salvaging the septic heart through targeting the interleukin-6/p38 mitogen-activated protein kinase signaling network

Ian G. Cannell, Michael B. Yaffe

CRITICAL CARE MEDICINE (2011)

Article Biochemistry & Molecular Biology

The MK5/PRAK Kinase and Myc Form a Negative Feedback Loop that Is Disrupted during Colorectal Tumorigenesis

Theresia R. Kress, Ian G. Cannell, Arjan B. Brenkman, Birgit Samans, Matthias Gaestel, Paul Roepman, Boudewijn M. Burgering, Martin Bushell, Andreas Rosenwald, Martin Eilers

MOLECULAR CELL (2011)

Article Multidisciplinary Sciences

The bromodomain protein Brd4 insulates chromatin from DNA damage signalling

Scott R. Floyd, Michael E. Pacold, Qiuying Huang, Scott M. Clarke, Fred C. Lam, Ian G. Cannell, Bryan D. Bryson, Jonathan Rameseder, Michael J. Lee, Emily J. Blake, Anna Fydrych, Richard Ho, Benjamin A. Greenberger, Grace C. Chen, Amanda Maffa, Amanda M. Del Rosario, David E. Root, Anne E. Carpenter, William C. Hahn, David M. Sabatini, Clark C. Chen, Forest M. White, James E. Bradner, Michael B. Yaffe

NATURE (2013)

Article Cell Biology

A Reversible Gene-Targeting Strategy Identifies Synthetic Lethal Interactions between MK2 and p53 in the DNA Damage Response In Vivo

Sandra Morandell, H. Christian Reinhardt, Ian G. Cannell, Jacob S. Kim, Daniela M. Ruf, Tanya Mitra, Anthony D. Couvillon, Tyler Jacks, Michael B. Yaffe

CELL REPORTS (2013)

Article Biochemistry & Molecular Biology

Clonal Decomposition and DNA Replication States Defined by Scaled Single-Cell Genome Sequencing

Emma Laks, Andrew McPherson, Hans Zahn, Daniel Lai, Adi Steif, Jazmine Brimhall, Justina Biele, Beixi Wang, Tehmina Masud, Jerome Ting, Diljot Grewal, Cydney Nielsen, Samantha Leung, Viktoria Bojilova, Maia Smith, Oleg Golovko, Steven Poon, Peter Eirew, Farhia Kabeer, Teresa Ruiz de Algara, So Ra Lee, M. Jafar Taghiyar, Curtis Huebner, Jessica Ngo, Tim Chan, Spencer Vatrt-Watts, Pascale Walters, Nafis Abrar, Sophia Chan, Matt Wiens, Lauren Martin, R. Wilder Scott, T. Michael Underhill, Elizabeth Chavez, Christian Steidl, Daniel Da Costa, Yussanne Ma, Robin J. N. Coope, Richard Corbett, Stephen Pleasance, Richard Moore, Andrew J. Mungall, Colin Mar, Fergus Cafferty, Karen Gelmon, Stephen Chia, Marco A. Marra, Carl Hansen, Sohrab P. Shah, Samuel Aparicio

Article Cell Biology

Transite: A Computational Motif-Based Analysis Platform That Identifies RNA-Binding Proteins Modulating Changes in Gene Expression

Konstantin Krismer, Molly A. Bird, Shohreh Varmeh, Erika D. Handly, Anna Gattinger, Thomas Bernwinkler, Daniel A. Anderson, Andreas Heinzel, Brian A. Joughin, Yi Wen Kong, Ian G. Cannell, Michael B. Yaffe

CELL REPORTS (2020)

Article Multidisciplinary Sciences

Landscapes of cellular phenotypic diversity in breast cancer xenografts and their impact on drug response

Dimitra Georgopoulou, Maurizio Callari, Oscar M. Rueda, Abigail Shea, Alistair Martin, Agnese Giovannetti, Fatime Qosaj, Ali Dariush, Suet-Feung Chin, Larissa S. Carnevalli, Elena Provenzano, Wendy Greenwood, Giulia Lerda, Elham Esmaeilishirazifard, Martin O'Reilly, Violeta Serra, Dario Bressan, Gordon B. Mills, H. R. Ali, Sabina S. Cosulich, Gregory J. Hannon, Alejandra Bruna, Carlos Caldas, S. Alon, M. Al Sa'd, S. Aparicio, G. Battistoni, S. Balasubramanian, R. Becker, B. Bodenmiller, E. S. Boyden, Marcel Burger, I. G. Cannell, H. Casbolt, N. Chornay, Y. Cui, A. Dariush, K. Dinh, A. Emenari, Y. Eyal-Lubling, J. Fan, A. Fatemi, E. Fisher, E. A. Gonzalez-Solares, C. Gonzalez-Fernandez, D. Goodwin, W. Greenwood, F. Grimaldi, G. J. Hannon, O. Harris, S. Harris, C. Jauset, J. A. Joyce, E. D. Karagiannis, T. Kovacevic, L. Kuett, R. Kunes, Yoldas A. Kupcu, D. Lai, E. Laks, H. Lee, M. Lee, G. Lerda, Y. Li, A. McPherson, N. Millar, C. M. Mulvey, F. Nugent, C. H. O'Flanagan, M. Paez-Ribes, I. Pearsall, F. Qosaj, A. J. Roth, O. M. Rueda, T. Ruiz, K. Sawicka, L. A. Sepulveda, S. P. Shah, A. Shea, A. Sinha, A. Smith, S. Tavare, S. Tietscher, I. Vazquez-Garcia, S. L. Vogl, N. A. Walton, A. T. Wassie, S. S. Watson, J. Weselak, S. A. Wild, E. Williams, J. Windhager, T. Whitmarsh, C. Xia, P. Zheng, X. Zhuang

Summary: Breast cancer heterogeneity plays a significant role in drug response and resistance. This study utilizes patient-derived tumor xenografts for drug testing and correlation with single-cell proteomic phenotypes revealed by mass cytometry, shedding light on the association between cellular heterogeneity and drug response and resistance.

NATURE COMMUNICATIONS (2021)

Article Multidisciplinary Sciences

Clonal fitness inferred from time-series modelling of single-cell cancer genomes

Sohrab Salehi, Farhia Kabeer, Nicholas Ceglia, Mirela Andronescu, Marc J. Williams, Kieran R. Campbell, Tehmina Masud, Beixi Wang, Justina Biele, Jazmine Brimhall, David Gee, Hakwoo Lee, Jerome Ting, Allen W. Zhang, Hoa Tran, Ciara O'Flanagan, Fatemeh Dorri, Nicole Rusk, Teresa Ruiz de Algara, So Ra Lee, Brian Yu Chieh Cheng, Peter Eirew, Takako Kono, Jenifer Pham, Diljot Grewal, Daniel Lai, Richard Moore, Andrew J. Mungall, Marco A. Marra, Andrew McPherson, Alexandre Bouchard-Cote, Samuel Aparicio, Sohrab P. Shah

Summary: Progress in defining genomic fitness landscapes in cancer, particularly those associated with copy number alterations (CNAs), has been hindered by the absence of time-series single-cell sampling and temporal statistical models. This study generated a large number of genomes from long-term time-series single-cell whole-genome sequencing of breast epithelium and primary triple-negative breast cancer (TNBC) patient-derived xenografts, revealing the impact of TP53 mutation and cisplatin chemotherapy on clonal fitness dynamics defined by CNAs. The findings show that TP53 mutation alters the fitness landscape, redistributing fitness across different clones associated with distinct CNAs, and that drug treatment can lead to the emergence of drug-resistant clones while eradicating high-fitness clones in untreated settings.

NATURE (2021)

Article Biology

Clonal transcriptomics identifies mechanisms of chemoresistance and empowers rational design of combination therapies

Sophia A. Wild, Ian G. Cannell, Ashley Nicholls, Katarzyna Kania, Dario Bressan, Gregory J. Hannon, Kirsty Sawicka

Summary: This study utilizes clonal transcriptomics with WILD-seq to analyze mouse models of TNBC and identifies NRF2 as a major mechanism of taxane resistance. It also discovers the collateral sensitivity of tumor models to asparagine deprivation therapy using L-asparaginase after docetaxel treatment.
Article Oncology

Three-dimensional imaging mass cytometry for highly multiplexed molecular and cellular mapping of tissues and the tumor microenvironment

Laura Kuett, Raul Catena, Alaz Ozcan, Alex Pluss, Peter Schraml, Holger Moch, Natalie de Souza, Bernd Bodenmiller

Summary: The article introduces a new imaging mass cytometry technology that allows for multiplexed tissue analysis in three dimensions. The study shows that this technology can reveal the complexity of cells and microenvironments, as well as phenomena occurring in three-dimensional space, such as tumor cell invasion.

NATURE CANCER (2022)

暂无数据